75592-11-9Relevant academic research and scientific papers
Imidazole Derivatives for the Treatment of Gastrointestinal Disorders
-
Page/Page column 10, (2009/01/24)
The present invention relates to novel compounds having a positive allosteric GABAB receptor (GBR) modulator effect, methods for the preparation of said compounds and to their use, optionally in combination with a GABAB agonist, for
IMIDAZOLE DERIVATIVES FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS
-
Page/Page column 27-28, (2010/11/27)
The present invention relates to novel imidazole derivatives having a positive allosteric GABAB receptor (GBR) modulator effect, methods for the preparation of said compounds and to their use, optionally in combination with a GABAB agonist, for the inhibi
GABA-B RECEPTOR MODULATORS
-
Page/Page column 33, (2008/06/13)
The present invention relates to novel imidazole derivatives having a positive allosteric GABAB receptor (GBR) modulator effect, methods for the preparation of said compounds and to their use, optionally in combination with a GABAB a
Synthesis of N,N,N'-Trisubstituted N"-Cyanoguanidines and N-Aryl-N'-(triorganostannyl)-N',N"-dicyanoguanidines
Kupchik, Eugene J.,Hanke, Hans E.,DiMarco, Jack P.,Chessari, Roy J.
, p. 105 - 106 (2007/10/02)
Bis(triphenylstannyl)carbodiimide reacts with 1,1,3-trisubstituted thioureas to give N,N,N'-trisubstituted N"-cyanoguanidines.Bis(triphenylstannyl)carbodiimide and bis(trimethylstannyl)carbodiimide react separately with ethyl N-arylthiocarbamates to give the corresponding N-aryl-N'-(triorganostannyl)-N',N"-dicyanoguanidines.
